# Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder

> **NCT00000375** · PHASE4 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)**

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Nortriptyline-lithium (NOR-Li)
- **PROCEDURE:** Bilateral electroconvulsive therapy (ECT)
- **DRUG:** Continuation therapy
- **BEHAVIORAL:** Continuation ECT

## Key facts

- **NCT ID:** NCT00000375
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000375, "Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00000375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*